Aleksandra Wieczorek

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Clinical Practice

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Targeted oncology

Journal of clinical medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski, Aleksandra Wieczorek
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review. Targeted oncology 19 (2) (2024)
Agata Marjańska, Katarzyna Pawinska-Wasikowska, Aleksandra Wieczorek, Monika Drogosiewicz, Bożenna Dembowska-Bagińska, Katarzyna Bobeff, Wojciech Mlynarski, Katarzyna Adamczewska-Wawrzynowicz, Jacek Wachowiak, Małgorzata Anna Krawczyk, Ninela Irga-Jaworska, Jadwiga Weclawek-Tompol, Krzyzstof Kalwak, Małgorzata Sawicka-Żukowska, Maryna Krawczuk-Rybak, Anna Raciborska, Agnieszka Mizia-Malarz, Agata Sobocińska-Mirska, Paweł Łaguna, Walentyna Balwierz, Jan Styczyński
Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma. Cancers 16 (5) (2024)
Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski, Aleksandra Wieczorek
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review. Targeted oncology 19 (2) (2024)
Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski, Aleksandra Wieczorek
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review. Targeted oncology (2024)
Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski, Aleksandra Wieczorek
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review. Targeted oncology 19 (2) (2024)
Urszula Żebrowska, Walentyna Balwierz, Jarosław Wechowski, Aleksandra Wieczorek
Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review. Targeted oncology 19 (2) (2024)
Agata Marjańska, Katarzyna Pawinska-Wasikowska, Aleksandra Wieczorek, Monika Drogosiewicz, Bożenna Dembowska-Bagińska, Katarzyna Bobeff, Wojciech Mlynarski, Katarzyna Adamczewska-Wawrzynowicz, Jacek Wachowiak, Małgorzata Anna Krawczyk, Ninela Irga-Jaworska, Jadwiga Weclawek-Tompol, Krzyzstof Kalwak, Małgorzata Sawicka-Żukowska, Maryna Krawczuk-Rybak, Anna Raciborska, Agnieszka Mizia-Malarz, Agata Sobocińska-Mirska, Paweł Łaguna, Walentyna Balwierz, Jan Styczyński
Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma. Cancers 16 (5) (2024)
Holger N Lode, Ruth Ladenstein, Sascha Troschke-Meurer, Linda Struppe, Nikolai Siebert, Maxi Zumpe, Karoline Ehlert, Stefanie Huber, Evgenia Glogova, Patrick Hundsdoerfer, Angelika Eggert, Anna Zaniewska-Tekieli, Walentyna Balwierz, Aleksandra Wieczorek
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy. Cancers 15 (13) (2023)
Aleksandra Wieczorek, Urszula Żebrowska, Marek Ussowicz, Agnieszka Sokół, Marzena Stypińska, Bożenna Dembowska-Bagińska, Katarzyna Pawinska-Wasikowska, Walentyna Balwierz
Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings-Real-World Data. Journal of clinical medicine 12 (16) (2023)
Karolina Bukowska-Strakova, Joanna Włodek, Ewelina Pitera, Magdalena Kozakowska, Anna Konturek-Cieśla, Maciej Cieśla, Monika Gońka, Witold Norbert Nowak, Aleksandra Wieczorek, Katarzyna Pawińska-Wąsikowska, Alicja Józkowicz, Maciej Siedlar
Role of HMOX1 Promoter Genetic Variants in Chemoresistance and Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia. International journal of molecular sciences 22 (3) (2021)